Analysis of Mucosal- Associated Invariant T Cell Levels And Their Correlation With Tumor Immune Status In Patients With Brain Tumors
DOI:
https://doi.org/10.46568/bios.v5i1.185Keywords:
Neurology, Brain Tumor, Mucosal Immunity, MAIT cells, TILs, Immune correlation, , Expression AnalysisAbstract
Introduction: Primary brain tumors refer to a heterogeneous group of tumors arising from cells within the CNS, and can be benign or malignant. In recent years, experimental evidence suggests that, despite the presence of blood-brain barrier (BBB) and lack of discrete lymphoid tissue, there are immunocompetent cells (TILs-Tumor infiltrating lymphocytes) within the brain parenchyma. Many of these cells are T-Lymphocytes known as CD8+ Mucosal-associated invariant T (MAIT) cells, which proliferate with stimulation, and are cytotoxic to tumor cells in vitro. To evaluate the frequency of unconventional MAIT cells in the setting of brain tumors by expression analysis of their three defining markers CD3D, KLRB1 (CD161) and a TCR a-chain variant Va7.2 (TRAV1-2 gene). Methodology: The study involved collecting EDTA blood samples and fresh brain tissue biopsies from selected population followed by RNA extraction and cDNA synthesis for measurement of relative expression analysis in blood and tissues samples. Expression data was generated by semi-quantitative real time PCR. Results: The outcome of this study demonstrated higher expression level of CD3D, KLRB1 (CD161) and a TCR a-chain variant Va7.2 (TRAV1-2 gene) in the blood of patients compared to the tissue samples showed little to no transmigration of these MAIT cells in the diseased tissues. Also, the expression of genes under-investigation was observed decreasing in both blood and tissue samples with the progression of tumor. Conclusion: MAIT cells might undergo depletion in the tumor micro-environment due to chronic activation induced exhaustion of these cells.
References
Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS. The epidemiology of glioma in adults: a "state of the science" review. Neuro Oncol. 2014 Jul;16(7):896-913
Stone, Jennifer D, and Lawrence J Stern. “CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement.” Journal of immunology (Baltimore, Md. : 1950) vol. 176,3 (2006): 1498-505.
Le Bourhis, Lionel et al. “Mucosal-associated invariant T cells: unconventional development and function.” Trends in immunology vol. 32,5 (2011): 212-8.
Dias J, Boulouis C, Gorin JB, van den Biggelaar RHGA, Lal KG, Gibbs A, Loh L, Gulam MY, Sia WR, Bari S, Hwang WYK, Nixon DF, Nguyen S, Betts MR, Buggert M, Eller MA, Broliden K, Tjernlund A, Sandberg JK, Leeansyah E. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. ProcNatlAcadSci U S A. 2018 Dec 4;115(49):E11513-E11522.
Xiao X, Cai J. Mucosal-Associated Invariant T Cells: New Insights into Antigen Recognition and Activation. Front Immunol. 2017 Nov 10;8:1540.
Nel, I., Bertrand, L., Toubal, A. et al. MAIT cells, guardians of skin and mucosa?. Mucosal Immunol 14, 803–814 (2021).
Bonaguro L, Schulte-Schrepping J, Netea MG, Händler K, Mukherjee S, Ulas T, Schultze JL, Aschenbrenner AC. Human variation in population-wide gene expression data predicts gene perturbation phenotype. iScience. 2022 Oct 12;25(11):105328.
Ussher JE, Klenerman P, Willberg CB. Mucosal-associated invariant T-cells: new players in anti-bacterial immunity. Front Immunol. 2014 Oct 8;5:450.
Sundström P, Szeponik L, Ahlmanner F, Quiding-Järbrink M. Tumor-infiltrating mucosal-associated invariant T (MAIT) cells retain expression of cytotoxic effector molecules. Oncotarget. 2019 Apr 19;10(29):2810-2823.
Mo J, Zheng L, Gao Z, Wu J, Bao Y. The Study of Mucosal-Associated Invariant T Cells in Colon Cancer and Roles in Immune Activities. Onco Targets Ther. 2021 Nov 16;14:5263-5273.
Chiba A, Murayama G, Miyake S. Mucosal-Associated Invariant T Cells in Autoimmune Diseases. Front Immunol. 2018 Jun 11;9:1333.
Trottein F, Paget C. Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Lung Infections. Front Immunol. 2018 Aug 2;9:1750.
Cosgrove C, Ussher JE, Rauch A, Gärtner K, Kurioka A, Hühn MH, Adelmann K, Kang YH, Fergusson JR, Simmonds P, Goulder P, Hansen TH, Fox J, Günthard HF, Khanna N, Powrie F, Steel A, Gazzard B, Phillips RE, Frater J, Uhlig H, Klenerman P. Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection. Blood. 2013 Feb 7;121(6):951-61.
Eberhard JM, Hartjen P, Schulze zurWiesch J. CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression. PLoS One. 2014 Nov 4;9(11):e111323.
Fergusson JR, Hühn MH, Swadling L, et al. CD161(int)CD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gut. Mucosal Immunol. 2016 Mar;9(2):401-13.
Shafique S, Haseeb HM, Bano K, Arshad A. Investigating Entosis and Autophagy Dynamics in Diverse Tumor Microenvironments , Pak-Euro Journal of Medical and Life Sciences: Vol. 7, 3 (2023) Dec: 219-226.
Di, Wang et al. “Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples.” Cancer science vol. 113,2 (2022): 756-769.
Peterfalvi, Agnes et al. “Invariant Valpha7.2-Jalpha33 TCR is expressed in human kidney and brain tumors indicating infiltration by mucosal-associated invariant T (MAIT) cells.” International immunology vol. 20,12 (2008): 1517-25.
Shoaib M, Haseeb HM, Bano K, Arshad A. Unraveling the Complexity of Immune Checkpoint Modulation in Gastrointestinal Malignancies, Pak-Euro Journal of Medical and Life Sciences: Vol. 6, 3 (2023) Sep: 269-276.
Arshad A, Deutsch E, Vozenin MC. Simultaneous irradiation of fibroblasts and carcinoma cells repress the secretion of soluble factors able to stimulate carcinoma cell migration. PLoS One. 2015 Jan 30;10(1):e0115447.
Shafiq A, Moore J, Suleman A, Faiz S, Farooq O, Arshad A, Tehseen M, Zafar A, Ali SH, Din NU, Loya A. Elevated soluble galectin-3 as a marker of chemotherapy efficacy in breast cancer patients: A prospective study. International journal of breast cancer. 2020 Mar 14;2020.
Lukasik Z, Elewaut D, Venken K. MAIT Cells Come to the Rescue in Cancer Immunotherapy? Cancers (Basel). 2020 Feb 11;12(2):413.
Ahtzaz K, Ali M, Arshad A. Comparative analysis of exon 11 mutations of brca1 gene in regard to circulating tumor dna (ctdna) & genomic dna in a cohort of breast cancer patients in Pakistan, December 2017: Asian Journal of Science and Technology Vol. 08, Issue, 12, pp.7029-7046.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Barha Latif, Hafiz Muhammad Haseeb Khaliq , Asad Ullah, Khawar Anwar, Adnan Arshad
This work is licensed under a Creative Commons Attribution 4.0 International License.
